Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2026-01-15 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
关于变更持续督导保荐代表人的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of continuous supervision sponsor representatives for Shanghai Chenguang Medical Technology Co., Ltd. It details the replacement of a sponsor representative due to work arrangements and provides a brief biography of the new representative. There is no financial data, no report attached or referenced as being published, and no mention of voting results or management changes at the board level. This is a regulatory announcement about sponsor representative changes related to ongoing supervision, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2026-01-15 Chinese
关于注销部分募集资金专项账户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the cancellation of certain special accounts for raised funds by Shanghai Chunguang Medical Technology Co., Ltd. It details the background of the fundraising, the management of the funds, the status of the special accounts, and the completion of the cancellation process. It includes references to regulatory approvals, audit reports on the fundraising, and agreements with banks and securities firms. The document is a formal public announcement about the management and cancellation of fundraising accounts rather than a full financial report or audit report. It does not contain comprehensive financial statements or detailed financial analysis. The document length is 2477 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it updates on the status and management of the company's fundraising activities and capital accounts.
2026-01-13 Chinese
第五届董事会第二十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 26th meeting of the 5th Board of Directors of Shanghai Chunguang Medical Technology Co., Ltd. It details the meeting's logistics, attendance, and the approval of a proposal regarding the use of idle raised funds for cash management. The document includes voting results and references related board and audit committee meeting resolutions. There is no detailed financial report or comprehensive financial data presented, nor is it a transcript or presentation. It is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short and focused on board decisions rather than full reports or regulatory filings.
2026-01-11 Chinese
国泰海通证券股份有限公司关于上海辰光医疗科技股份有限公司使用闲置募集资金进行现金管理的核查意见
Regulatory Filings
2026-01-11 Chinese
合计持股5%以上股东权益变动达到1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a change in shareholding by a shareholder and their related parties, specifically indicating a change in ownership percentage crossing a 1% threshold. It includes details about the shareholder, the number of shares reduced, and confirms compliance with relevant securities laws. There is no financial report, earnings data, or management discussion. The document fits the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2026-01-11 Chinese
关于公司使用闲置募集资金进行现金管理公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shanghai Chenguang Medical Technology Co., Ltd. regarding the use of idle raised funds for cash management. It details the amount of funds raised, their usage, storage, and the decision-making process for investing idle funds in low-risk financial products. The document includes board resolutions and opinions from the sponsor institution confirming compliance with regulatory requirements. It does not contain financial statements or comprehensive financial data but is a disclosure about the company's capital management activities related to fundraising proceeds. The document length is 3589 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this fits the category of a Capital/Financing Update (CAP) rather than a full Annual Report or Interim Report.
2026-01-11 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.